Data Tables

View HTML		View PDF
Section IX
9.1a	Waiting List Patient Characteristics at End of Year Liver Waiting List Active Waitlist Patients, 1997 to 2006	(47 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Patient Status
	Previous Transplant Same Organ
	Time on Waiting List
9.1b	Waiting List Patient Characteristics at End of Year Liver Waiting List Active and Inactive Patient Comparison, 2002 to 2006	(37 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
9.2a	Events 7 & 15 Days After Listing 2005 and 2006 Liver Registrations with Initial Status 1	(22 k)
9.2b	Events 30 Days After Snapshot of Prevalent Waiting List Adult Patients on Liver Waiting List on Jan. 1, 2006	(36 k)
	30 Days After Snapshot
	60 Days After Snapshot
	90 Days After Snapshot
9.2c	Events 30 Days After Snapshot of Prevalent Waiting List Pediatric Patients on Liver Waiting List on Jan. 1, 2006	(35 k)
	30 Days After Snapshot
	60 Days After Snapshot
	90 Days After Snapshot
9.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Liver Waiting List	(58 k)
	Age
	Blood Type
	Diagnosis
	Gender
	Race
	Patient Status
9.4a	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Livers	(49 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
9.4b	Transplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor Livers	(48 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Relation
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
9.5	Incidence of Transplant, 1997 to 2006 Liver Transplants per 1 Million Population	(29 k)
9.6a	Immunosuppression Use for Induction, 1997 to 2006 Recipients with Liver Transplants	(29 k)
9.6b	Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Liver Transplants	(31 k)
9.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Liver Transplants	(29 k)
9.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Liver Transplants	(30 k)
9.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Liver Transplants	(31 k)
9.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Liver Transplants	(31 k)
9.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Liver Transplants	(31 k)
9.6h	Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Liver Transplants	(34 k)
9.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Liver Transplants	(30 k)
9.7a	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor Liver Transplantation	(82 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Age
	Age
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
9.7b	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Liver Transplantation	(74 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Age
	Age
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Any Organ
	Diagnosis
9.8a	Adjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.8b	Adjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.9a	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.9b	Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.10a	Unadjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(47 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
9.10b	Unadjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Relation
	Donor Age
	Previous Transplant Same Organ
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
9.11a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.11b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.12a	Adjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.12b	Adjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(36 k)
	Age
	Gender
	Race
	Diagnosis
9.13a	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.13b	Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.14a	Unadjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(47 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Age
	Diagnosis
	Cold Ischemic Time
	On Life Support at Tx
	Hospitalized at Tx
9.14b	Unadjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Center Volume
	Donor Relation
	Donor Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
9.15a	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants	(22 k)
9.15b	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants	(22 k)
9.16	Prevalence of People Living with a Functioning Transplant at End of Year Liver Recipients, 1997 to 2005	(47 k)
	Blood Type
	Residency
	Gender
	Patient Status
	Race
	Donor Type
	Age
	Diagnosis
	On Life Support at Tx
	Hospitalized at Tx
	Previous Transplant Same Organ
	Previous Transplant Any Organ
9.17	Transplants by State and Transplant Center, 1997 to 2006 Liver	(67 k)